Purchase Order VA580W17090
Award Date 2/25/11
Potential Completion Date 3/25/11
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System, a noninvasive regenerative medicine product. The $4,820.98 firm-fixed-price purchase order contract was awarded on January 10, 2011, with a completion date of February 10, 2011. The contract was awarded under Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A for...
- This federal contract award is for the purchase of the Provant Therapy System from Regenesis Biomedical Inc., a medical technology company. The $4,820.98 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) on December 28, 2010, with an ultimate completion date of January 28, 2011. The contract was awarded against Regenesis Biomedical's existing GSA Schedule 65-II-A contract for medical equipment and supplies, and did not utilize any set-aside designations....
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm-fixed-price purchase order is for the provision of Regenesis Biomedical's Provant Therapy System, a patented medical device indicated for the palliative treatment of post-operative pain and edema. The contract has a period of performance ending on March 24, 2011 and was awarded on February 24, 2011. The award was made...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm fixed-price purchase order contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with any set-aside designations. Regenesis Biomedical,...
- This federal contract award to Regenesis Biomedical Inc. is for the supply of the company's Provant Therapy System medical device and related rental/leasing services to the U.S. Department of Veterans Affairs (VA). The $4,882.79 firm-fixed-price purchase order was awarded on February 16, 2011, with a completion date of March 16, 2011. The contract was awarded against Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the Provant Therapy System. The $3,645.14 firm fixed-price purchase order was awarded on October 15, 2010, with a completion date of November 15, 2010. The contract was not set aside for any preferential contracting vehicle. Regenesis Biomedical provides the Provant Therapy System, a patented noninvasive regenerative medicine product, to the VA...
- This federal contract award is for the procurement of the Provant Therapy System, a noninvasive regenerative medicine product developed by Regenesis Biomedical Inc. The contract, valued at $4,820.98, was awarded to Regenesis Biomedical Inc. by the Department of Veterans Affairs (VA) on June 21, 2011, with an ultimate completion date of July 21, 2011. The contract is a firm fixed-price purchase order, and it does not utilize any set-aside designations. Regenesis Biomedical Inc. is the prime...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The contract does not utilize any set-aside designations. Based on the information provided, Regenesis Biomedical acts as the prime contractor and does not subcontract...